North America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2240 | Pages: 143 | May 2017 | Region: North America


The North America Cancer Biomarkers Market was worth USD 3.52 billion in 2016 and estimated to be growing at a CAGR of 10.9%, to reach USD 5.9 billion by 2021. North America accounted for the largest share of the cancer biomarkers market.

Cancer biomarkers are molecules secreted by a tumour or a precise response of the body to the existence of cancer. These are also referred as matter or processes which are symptomatic of the presence of cancer in the human body, which enhances the cancer recognition and facilitate high speed, non-invasive diagnosis using genomics and proteomics based tools.

The increasing incidence of cancer, growing demand for highly developed diagnostics tests, improved awareness and acceptance of diagnostics tests, progression in technologies and the need for early stage cancer diagnosis propels the growth of this market. But, inadequately suited regulatory and reimbursement systems for biomarker tests and necessity of high capital investments for biomarker innovation and development are estimated to hinder the growth of this market during the forecast period.

The North America cancer biomarkers market is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on services market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the basis of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is segregated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is among omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies segment is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.

Based on geography, the market is analysed under various countries namely, USA and Canada. USA is dominating the cancer biomarkers market followed by Canada.

Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  2. North America Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  3. North America Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  4. North America Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  5. North America Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  6. North America Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  7. North America Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  8. North America Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  9. North America Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  10. North America Assay development  Market By Region, From 2016-2021 ( USD Billion )
  11. North America Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  12. North America Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  13. North America Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  14. North America Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  15. North America Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  16. North America Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  17. North America Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  18. North America Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  19. North America Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  20. North America Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  21. North America Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  22. North America Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  23. North America Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  24. North America Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  25. North America Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  26. North America Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  27. North America Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  28. North America IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  29. United States Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  30. United States Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  31. United States Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  32. United States Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  33. United States Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  34. Canada Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  35. Canada Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  36. Canada Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  37. Canada Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  38. Canada Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  39. North America Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  40. North America Genomics Market By Region, From 2016-2021 ( USD Billion )
  41. North America Proteomics Market By Region, From 2016-2021 ( USD Billion )
  42. North America Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  43. North America Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  44. North America Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  45. United States Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  46. Canada Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
Middle-East and Africa Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and ...
Latin America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Asia-Pacific Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers...
Europe Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers valid...
North America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation a...
Middle East and Africa Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Car...
Latin America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Asia-Pacific Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascula...
Europe Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) –...
North America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) - Global M...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.